Anti-Hypertensive Property of an NO Nanoparticle in an Adenine-Induced Chronic Kidney Disease Young Rat Model

Hypertension is the most common complication of chronic kidney disease (CKD) in children but is still poorly controlled. Nitric oxide (NO) deficiency plays a pivotal role in CKD and hypertension. NO is known to have health benefits, while NO typically has a short half-life and is not specifically ta...

Full description

Bibliographic Details
Published in:	Antioxidants
Main Authors:	You-Lin Tain, Hung-Wei Yang, Chih-Yao Hou, Guo-Ping Chang-Chien, Sufan Lin, Chien-Ning Hsu
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Subjects:	nitric oxide chronic kidney disease asymmetric dimethylarginine hypertension renin–angiotensin system oxidative stress
Online Access:	https://www.mdpi.com/2076-3921/12/2/513

Similar Items

Sodium Thiosulfate Improves Hypertension in Rats with Adenine-Induced Chronic Kidney Disease
by: Chien-Ning Hsu, et al.
Published: (2022-01-01)

Developmental Origins of Kidney Disease: Why Oxidative Stress Matters?
by: Chien-Ning Hsu, et al.
Published: (2020-12-01)

The NOS/NO System in Renal Programming and Reprogramming
by: You-Lin Tain, et al.
Published: (2023-08-01)

Perinatal Resveratrol Therapy Prevents Hypertension Programmed by Maternal Chronic Kidney Disease in Adult Male Offspring: Implications of the Gut Microbiome and Their Metabolites
by: Chien-Ning Hsu, et al.
Published: (2020-12-01)

Melatonin Prevents Chronic Kidney Disease-Induced Hypertension in Young Rat Treated with Adenine: Implications of Gut Microbiota-Derived Metabolites
by: Chien-Ning Hsu, et al.
Published: (2021-07-01)

Oxidative Stress-Induced Hypertension of Developmental Origins: Preventive Aspects of Antioxidant Therapy
by: You-Lin Tain, et al.
Published: (2022-03-01)

Renoprotective Effects of Melatonin in Young Spontaneously Hypertensive Rats with L-NAME
by: Ming-Chou Cheng, et al.
Published: (2014-06-01)

Perinatal Oxidative Stress and Kidney Health: Bridging the Gap between Animal Models and Clinical Reality
by: You-Lin Tain, et al.
Published: (2022-12-01)

Asymmetric Dimethylarginine (ADMA) in Pediatric Renal Diseases: From Pathophysiological Phenomenon to Clinical Biomarker and Beyond
by: Chien-Ning Hsu, et al.
Published: (2021-09-01)

Antihypertensive Effects of a Sodium Thiosulfate-Loaded Nanoparticle in a Juvenile Chronic Kidney Disease Rat Model
by: You-Lin Tain, et al.
Published: (2024-12-01)

Protection by Means of Perinatal Oral Sodium Thiosulfate Administration against Offspring Hypertension in a Rat Model of Maternal Chronic Kidney Disease
by: You-Lin Tain, et al.
Published: (2023-06-01)

Protective Effect of Resveratrol on Kidney Disease and Hypertension Against Microplastics Exposure in Male Juvenile Rats
by: You-Lin Tain, et al.
Published: (2024-11-01)

The role of L-arginine in the pathogenesis of essential arterial hypertension
by: V. A. Shcherbak, et al.
Published: (2024-03-01)

Protective Role of Taurine on Rat Offspring Hypertension in the Setting of Maternal Chronic Kidney Disease
by: You-Lin Tain, et al.
Published: (2023-11-01)

The influence of renin angiotensin aldosterone system blockers on asymmetric dimethylarginine levels in patients with chronic glomerulonephritis
by: Heleniak Zbigniew, et al.
Published: (2016-12-01)

Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
by: You‐Lin Tain, et al.
Published: (2017-03-01)

Sex Differences of Oxidative Stress to Cholestatic Liver and Kidney Injury in Young Rats
by: Kow-Aung Chang, et al.
Published: (2013-04-01)

Changes in nitric oxide inhibitors and mortality in critically ill patients: a cohort study
by: Karoline Myglegård Mortensen, et al.
Published: (2024-08-01)

Role of Asymmetric Dimethylarginine in Psychiatric Disorders
by: Selma Bozkurt Zincir, et al.
Published: (2014-08-01)

Nitric Oxide Metabolites and Asymmetric Dimethylarginine Concentrations in Breast Milk
by: Hakan Öztürk, et al.
Published: (2017-04-01)

Nitric Oxide Synthesis Metabolites—As Potential Markers in Chronic Kidney Disease in Children
by: Joanna Piechowicz, et al.
Published: (2022-08-01)

Animal Models for DOHaD Research: Focus on Hypertension of Developmental Origins
by: Chien-Ning Hsu, et al.
Published: (2021-05-01)

Effects of Taxifolin in Spontaneously Hypertensive Rats with a Focus on Erythrocyte Quality
by: Tomas Jasenovec, et al.
Published: (2022-12-01)

Dietary Supplementation with Cysteine during Pregnancy Rescues Maternal Chronic Kidney Disease-Induced Hypertension in Male Rat Offspring: The Impact of Hydrogen Sulfide and Microbiota-Derived Tryptophan Metabolites
by: Chien-Ning Hsu, et al.
Published: (2022-02-01)

Mechanisms of endothelial dysfunction in obesity-associated hypertension
by: N.S. Lobato, et al.
Published: (2012-05-01)

Acute L-Arginine supplementation does not increase nitric oxide production in healthy subjects
by: Alvares Thiago, et al.
Published: (2012-06-01)

The relationship of asymmetric dimethylarginine levels with uncontrolled arterial hypertension and hypertension disease stage
by: Aleksandr N. Stafeev, et al.
Published: (2023-11-01)

Metabolic Signature of Arrhythmogenic Cardiomyopathy
by: Chiara Volani, et al.
Published: (2021-03-01)

High plasma concentrations of asymmetric dimethylarginine inhibit ischemic cardioprotection in hypercholesterolemic rats
by: M.B.P. Landim, et al.
Published: (2013-05-01)

Revitalizing cardiac health in chronic renal failure: the synergistic effects of angiotensin-converting enzyme inhibitors and vitamin C in modulating nitric oxide and left ventricular hypertrophy
by: Azouaou Leila, et al.
Published: (2023-04-01)

Antihypertensive Effect of Dietary β-Conglycinin in the Spontaneously Hypertensive Rat (SHR)
by: Koji Kawabeta, et al.
Published: (2022-05-01)

The Impact of Nutrient Intake and Metabolic Wastes during Pregnancy on Offspring Hypertension: Challenges and Future Opportunities
by: You-Lin Tain, et al.
Published: (2023-03-01)

Developmental and Early Life Origins of Hypertension: Preventive Aspects of Melatonin
by: You-Lin Tain, et al.
Published: (2022-05-01)

Oxidative Stress in Maternal and Offspring Kidney Disease and Hypertension: A Life-Course Perspective
by: Pei-Chen Lu, et al.
Published: (2025-03-01)

Does the Inhibitory Action of Asymmetric Dimethylarginine (ADMA) on the Endothelial Nitric Oxide Synthase Activity Explain Its Importance in the Cardiovascular System? The ADMA Paradox
by: Dimitrios Tsikas
Published: (2017-07-01)

Serum Asymmetric Dimethylarginine Levels in Patients with Vasovagal Syncope
by: Adem Atıcı, et al.
Published: (2019-10-01)

Editorial: Pharmacology of L-Arginine and L-Arginine-Rich Food
by: Burkhard Poeggeler, et al.
Published: (2021-08-01)

Altered expression of the L-arginine/nitric oxide pathway in ovarian cancer: metabolic biomarkers and biological implications
by: Linfeng Chen, et al.
Published: (2023-09-01)

Asymmetric dimethylarginine (ADMA) and endothelial dysfunction: implications for atherogenesis
by: Maurício Batista Paes Landim, et al.
Published: (2009-05-01)

Crosstalk between renin and arachidonic acid (and its metabolites)
by: Undurti N. Das, et al.
Published: (2025-02-01)